- Van Cutsem, E., Paccard, C., Chiron, M., & Tabernero, J. (2020). Impact of prior bevacizumab treatment on VEGF-A and PIGF levels and outcome following second-line aflibercept treatment: Biomarker post hoc analysis of the VELOUR trial. Clinical Cancer Research, 26(3), 717-725. doi: 10.1158/1078-0432.CCR-19-1985
Impact of prior bevacizumab treatment on VEGF-A and PIGF levels and outcome following second-line aflibercept treatment: Biomarker post hoc analysis of the VELOUR trial
on 27 d'abril de 2020
with No hi ha comentaris
Deixa un comentari